Descubra un plan de control de peso que pueda ser adecuado para usted con opciones de inyeccin de GLP-1 aprobadas por la FDA para bajar de peso
The Cleveland Clinic explains that GLP-1 agonist medications like Ozempic and Mounjaro work by triggering your pancreas to release more insulin, adding: The slowed digestion also helps decrease blood sugar spikes. These factors can play into appetite, digestion, the metabolization of food into energyand in turn, possibly weight loss
However, the weight loss seen in this study of people with type 2 diabetes is broadly comparable with that previously observed with injectable GLP-1
Side effects tend to mirror those of GLP-1 agonists: Nausea Diarrhea Decreased appetite Possible gallbladder effects (as with all rapid weight loss) Minimal risk of hypoglycemia when used without insulin Importantly, GIP on its own does not cause hypoglycemia , making it a relatively safe therapeutic target
I am monitoring the Lipedema World Congress site so we can see the full presentation online, hopefully soon
Healthcare providers carefully evaluate each patient's situation, considering factors such as comorbid conditions and medication interactions